Alexandria Real Estate Equities, Inc. (NYSE: ARE) is one of the 11 most oversold S&P 500 stocks heading into 2026. BofA analyst Joshua Dennerlein slashed the price target on the stock to $50 from $57, maintaining a Neutral rating on its shares.

The adjustment followed the company’s investor day, where management extended the timeline for the life science market to reach equilibrium to 4-5 years, up from 2-3 years. Dennerlein also noted the company reduced its FY26 guidance.

BMO Capital recently trimmed its price target for ARE to $60 from $67, citing a quarterly dividend cut and lowered earnings guidance for next year as reasons. The company declared a quarterly cash dividend of $0.72 per common share for Q4 2025, a 45% sequential decline.

As of December 10, Wall Street analysts have a consensus Hold rating on ARE. The one-year average share price target of $63.08 implies a 36% upside. ARE is a life sciences real estate investment trust that has seen a 4% decline over the past week and a year-to-date fall of over 52%.

While ARE has investment potential, certain AI stocks may offer greater upside potential with less downside risk. For an undervalued AI stock benefiting from Trump-era tariffs and the onshoring trend, see Insider Monkey’s free report on the best short-term AI stock.

Disclosure: None.

Read more at Yahoo Finance: Is Alexandria Real Estate Equities, Inc. (ARE) the Most Oversold S&P 500 Stock Heading into 2026?